Samir Chandrakant Patel

Insider Reports History

Location
One Penn Plaza, 19 Th Floor, New York, NY
Signature
/s/ Andrew Oxtoby, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samir Chandrakant Patel:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Allovir, Inc. Director Common Stock 252K $2.54M $10.08 Mar 18, 2025 Direct
Allovir, Inc. Director Common Stock 101K $1.02M $10.08 Mar 18, 2025 Indirect
Kalaris Therapeutics, Inc. Director Stock Option (Right to Buy) 18K Apr 10, 2025 Direct

Insider Reports Filed by Samir Chandrakant Patel

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KLRS Kalaris Therapeutics, Inc. Apr 10, 2025 1 $0 4 Apr 11, 2025 Director
KLRS Kalaris Therapeutics, Inc. Mar 18, 2025 3 $0 4 Mar 18, 2025 Director
KLRS Kalaris Therapeutics, Inc. Mar 18, 2025 0 $0 3 Mar 18, 2025 Director